# Nutritional Therapy to Incretin-based Anti-obesity Medications in the Management of Gastrointestinal Adverse Events

> **NCT06431308** · NA · RECRUITING · sponsor: **Ariel University** · enrollment: 120 (estimated)

## Conditions studied

- Obesity; Drug

## Interventions

- **BEHAVIORAL:** nutritional intervention

## Key facts

- **NCT ID:** NCT06431308
- **Lead sponsor:** Ariel University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-30
- **Primary completion:** 2026-02-01
- **Final completion:** 2026-03-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06431308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06431308, "Nutritional Therapy to Incretin-based Anti-obesity Medications in the Management of Gastrointestinal Adverse Events". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06431308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*